DIAGNOS Statistics
Total Valuation
DIAGNOS has a market cap or net worth of 15.32 million. The enterprise value is 15.20 million.
| Market Cap | 15.32M |
| Enterprise Value | 15.20M |
Important Dates
The last earnings date was Thursday, July 17, 2025.
| Earnings Date | Jul 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 101.86M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +21.23% |
| Shares Change (QoQ) | +5.60% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 96.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 212.19 |
| PB Ratio | 94.48 |
| P/TBV Ratio | 94.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.10 |
| EV / Sales | 199.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.98 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 13.18.
| Current Ratio | 1.11 |
| Quick Ratio | 1.08 |
| Debt / Equity | 13.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.84 |
| Interest Coverage | -6.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -111.17% |
| Return on Invested Capital (ROIC) | -139.02% |
| Return on Capital Employed (ROCE) | -736.62% |
| Revenue Per Employee | 3,282 |
| Profits Per Employee | -135,554 |
| Employee Count | 22 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.42% in the last 52 weeks. The beta is -0.68, so DIAGNOS's price volatility has been lower than the market average.
| Beta (5Y) | -0.68 |
| 52-Week Price Change | -37.42% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.20 |
| Relative Strength Index (RSI) | 50.88 |
| Average Volume (20 Days) | 77,139 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DIAGNOS had revenue of 72,214 and -2.98 million in losses. Loss per share was -0.03.
| Revenue | 72,214 |
| Gross Profit | -656,459 |
| Operating Income | -2.66M |
| Pretax Income | -2.98M |
| Net Income | -2.98M |
| EBITDA | -2.65M |
| EBIT | -2.66M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 2.25 million in cash and 2.14 million in debt, giving a net cash position of 113,894.
| Cash & Cash Equivalents | 2.25M |
| Total Debt | 2.14M |
| Net Cash | 113,894 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 162,180 |
| Book Value Per Share | 0.00 |
| Working Capital | 242,778 |
Cash Flow
In the last 12 months, operating cash flow was -2.53 million and capital expenditures -9,547, giving a free cash flow of -2.54 million.
| Operating Cash Flow | -2.53M |
| Capital Expenditures | -9,547 |
| Free Cash Flow | -2.54M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -3,684.24% |
| Pretax Margin | -4,129.65% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DIAGNOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.23% |
| Shareholder Yield | n/a |
| Earnings Yield | -19.46% |
| FCF Yield | -16.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 24, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 24, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
DIAGNOS has an Altman Z-Score of -19.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.48 |
| Piotroski F-Score | 3 |